Work

S1669 Assessment of Resmetirom Efficacy (80 mg vs 100 mg) Stratified by Baseline Body Mass Index and Weight in Patients From the MAESTRO-NASH Trial

Year: 2024

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0001036044.63596.59

Authors: Mazen Nouredden, Jörn M. Schattenberg, Rebecca Taub, Dominic Labriola, Rohit Loomba

Institutions: Houston Methodist, Saarland University, Madrigal Pharmaceuticals (United States), University of California San Diego

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403721812

Cites:

Cited by: 3

Related to: 10